Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2 studies found for:    NCT01183468
Show Display Options
Rank Status Study
1 Terminated
Has Results
A Research Trial of Aralast in New Onset Diabetes (RETAIN)
Condition: Diabetes Mellitus, Type 1
Interventions: Biological: Aralast NP 45 mg dose;   Biological: Aralast NP 90 mg dose;   Biological: Aralast NP 180 mg dose
2 Withdrawn A Research Trial of Aralast NP in New Onset Diabetes (RETAIN) - Part II
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Aralast NP;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.